FORMULATION AND EVALUATION OF INVASOMAL GEL OF ADAPALENE FOR EFFECTIVE ACNE TREATMENT
DOI:
https://doi.org/10.22159/ajpcr.2025v18i8.55143Keywords:
Invasome gel,, Topical treatment, Acne, Antiacne, Adapalene, ClindamycinAbstract
Objectives: The goal of the present study is to develop and evaluate an invasomal gel of adapalene (ADP) for the effective treatment of acne.
Methods: ADP loaded invasomal gel was prepared with required modifications after optimizing formulation variables on the basis of physicochemical properties and % drug entrapment. The data obtained from in vitro drug release study was plotted in various kinetic models following in vivo antiacne activity of ADP invasomal gel and observing the zone of inhibition, index of inflammatory strength, and acne power.
Results: The drug content of ADP loaded invasomal gel was lucrative, as the value did not stray from 99.45%. The maximum percentage of drug content was found to be in formulation AIG4, 99.45±0.25%. ADP -loaded invasomal gel had profitable drug content because the value stayed within the range of 99.45%. Formulation AIG4 had the highest proportion of medication content, 99.45±0.25%. The optimized invasomal formulation (AIG4) was shown to match well with Korsmeyers-Peppas model kinetics, which characterizes drug release as a time-dependent diffusion process, useful in the development of efficient transdermal drug delivery systems for ADP, which could lead to a more successful and patient-friendly treatment for acne and other skin conditions.
Conclusion: With a high capacity for skin penetration and effectiveness in treating acne, our results suggest that ADP -loaded invasome gel is a promising lipid-based nanosystem for topical ADP administration.
Downloads
References
1. Vidya K, Lakshmi PK. Cytotoxic effect of transdermal invasomal anastrozole gel on MCF-7 breast cancer cell line. J App Pharm Sci. 2019;9(3):50-8. doi: 10.7324/JAPS.2019.90308
2. Rusu A, Tanase C, Pascu GA, Todoran N. Recent advances regarding the therapeutic potential of adapalene. Pharmaceuticals (Basel). 2020;13(9):217. doi: 10.3390/ph13090217, PMID 32872149
3. Weiss JS, Thiboutot DM, Hwa J, Liu Y, Graeber M. Long-term safety and efficacy study of adapalene 0.3% gel. J Drugs Dermatol. 2008;7(6):s24-8. PMID 18575223
4. Jain AK, Jain A, Garg NK, Agarwal A, Jain A, Jain SA, et al. Adapalene loaded solid lipid nanoparticles gel: An effective approach for acne treatment. Colloids Surf B Biointerfaces. 2014;121:222-9. doi: 10.1016/j.colsurfb.2014.05.041, PMID 25016424
5. Najafi-Taher R, Ghaemi B, Amani A. Delivery of adapalene using a novel topical gel based on tea tree oil nano-emulsion: Permeation, antibacterial and safety assessments. Eur J Pharm Sci. 2018;120:142-51. doi: 10.1016/j.ejps.2018.04.029, PMID 29684425
6. Singhai M, Kori ML. Formulation and characterization of invasomes containing adapalene using box-behnken design. Int J Pharm Sci Drug Res. 2025;17(3):234-42. doi: 10.25004/IJPSDR.2025.170303
7. Qadri GR, Ahad A, Aqil M, Imam SS, Ali A. Invasomes of isradipine for enhanced transdermal delivery against hypertension: Formulation, characterization, and in vivo pharmacodynamic study. Artif Cells Nanomed Biotechnol. 2017;45(1):139-45. doi: 10.3109/21691401.2016.1138486, PMID 26829018
8. Mahtab A, Anwar M, Mallick N, Naz Z, Jain GK, Ahmad FJ. Transungual delivery of ketoconazole nanoemulgel for the effective management of onychomycosis. AAPS PharmSciTech. 2016;17(6):1477-90. doi: 10.1208/s12249-016-0488-0, PMID 26857516
9. Thatai P, Sapra B. Transungual gel of terbinafine hydrochloride for the management of onychomycosis: Formulation, optimization, and evaluation. AAPS PharmSciTech. 2017;18(6):2316-28. doi: 10.1208/ s12249-017-0711-7, PMID 28116600
10. El-Nabarawi MA, Shamma RN, Farouk F, Nasralla SM. Dapsone-loaded invasomes as a potential treatment of acne: Preparation, characterization, and in vivo skin deposition assay. AAPSPharmSciTech. 2018;19(5):2174-84. doi: 10.1208/s12249-018-1025-0, PMID 29725903
11. Aqil M, Ahad A, Sultana Y, Ali A. Status of terpenes as skin penetration enhancers. Drug Discov Today. 2007;12(23-24):1061-7. doi: 10.1016/j. drudis.2007.09.001, PMID 18061886
12. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966;45(4):493-6. doi: 10.1093/ajcp/45.4-ts.493, PMID 5325707
13. Gilani SJ, Bin Jumah MN, Fatima F, Al-Abbasi FA, Afzal M, Alzarea SI, et al. Hibiscetin attenuates lipopolysaccharide-evoked memory impairment by inhibiting BDNF/caspase-3/NF-κB pathway in rodents. PeerJ. 2024;12:e16795. doi: 10.7717/peerj.16795, PMID 38313003
14. Kazmi SA, Iqbal R, Al-Doaiss AA, Ali M, Hussain R, Latif F, et al. Azoxystrobin-induced oxidative stress in gills, hematological biomarkers and histopathological ailments in fresh water fish. Pak Vet J. 2023;43(2):321-326.
15. Jatav R, Raj V, Sirohi B, Lariya S. Evaluation of in vivo anti-acne activity of flower extract of Withania coagulans. Curr Res Pharm Sci. 2024;13(4):172-8. doi: 10.24092/CRPS.2023.130403
16. Shah KP, Srivastava RS. Evaluation of anti-oxidant and antiacne activities (in-vitro) of the formulated herbal gels. Int J Curr Pharm Res. 2015;7(3):47-50.
17. Anwar E, Ramadon D, Harmita. Formulation and evaluation of gel and emulgel of chili extract (Capsicum frutescens L.) as topical dosage forms. Int J Pharm Pharm Sci. 2014;6Suppl 3:13-6.
18. Garg T. Current nanotechnological approaches for an effective delivery of bio-active drug molecules in the treatment of acne. Artif Cells Nanomed Biotechnol. 2016;44(1):98-105. doi: 10.3109/21691401.2014.916715, PMID 24844191
19. Chang RK, Raw A, Lionberger R, Yu L. Generic development of topical dermatologic products: Formulation development, process development, and testing of topical dermatologic products. AAPS J. 2013;15:41-52. doi: 10.1208/s12248-015-9823-8, PMID 26338233
20. Cereda CM, De Araujo DR, Brunetto GB, De Paula E. Liposomal prilocaine: preparation, characterization, and in vivo evaluation. J Pharm Pharm Sci. 2004;7(2):235-40. PMID 15367381
21. Zaenglein AL, Pathy AL, Schlosser BJ, Alikhan A, Baldwin HE, Berson DS, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-73.e33. doi: 10.1016/j. jaad.2015.12.037, PMID 26897386
22. Gollnick HP, Zouboulis CC, Akamatsu H, Kurokawa I, Schulte A. Pathogenesis and pathogenesis related treatment of acne. J Dermatol. 1991;18(9):489-99. doi: 10.1111/j.1346-8138.1991.tb03122.x, PMID 1838558
23. Kircik LH. Synergy and its clinical reievance in topical acne therapy. J Clin Aesthetic Dermatol. 2011;4(11):30-3. PMID 22125656
24. Ahmadi F, Rashed Marandi F, Saghari H, Emameh Kou H. Evaluation of antibiogram pattern of Propionibacterium acnes obtained from skin of patients with acne vulgaris. Pajoohandeh J. 2007;12:229-34.
25. Leyden JJ. A review of the use of combination therapies for the treatment of acne vulgaris. J Am Acad Dermatol. 2003;49(3):S200-10. doi: 10.1067/s0190-9622(03)01154-x, PMID 12963896
26. Del Rosso JQ, Schmidt NF. A review of the anti-inflammatory properties of clindamycin in the treatment of acne Vulgaris. Cutis. 2010;85(1):15-24. PMID 20184207
27. Armillei MK, Lomakin IB, Del Rosso JQ, Grada A, Bunick CG. Scientific rationale and clinical basis for clindamycin use in the treatment of dermatologic disease. Antibiotics (Basel). 2024;13(3):270. doi: 10.3390/antibiotics13030270, PMID 38534705
28. Baldwin H, Webster G, Stein Gold L, Callender V, Cook-Bolden FE, Guenin E. 50 years of topical retinoids for acne: Evolution of treatment. Am J Clin Dermatol. 2021;22(3):315-27. doi: 10.1007/s40257-021- 00594-8, PMID 33871811
29. Shroot B, Michel S. Pharmacology and chemistry of adapalene. J Am Acad Dermatol. 1997;36(6):S96-S103. doi: 10.1016/S0190- 9622(97)70050-1
Published
How to Cite
Issue
Section
Copyright (c) 2025 Manu Singhai Manu; Mohan L Kori
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
